tiprankstipranks
Kyverna Therapeutics, Inc. (KYTX)
NASDAQ:KYTX
US Market
KYTX
Kyverna Therapeutics, Inc.
RESEARCH TOOLSreports

Kyverna Therapeutics, Inc. (KYTX) Cash flow

1,006 Followers

Kyverna Therapeutics, Inc. Cash Flow

KYTX's free cash flow for Q4 2025 was $-33.52M. For the 2025 fiscal year, KYTX's free cash flow was decreased by $-37.26M and operating cash flow was $-33.53M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -153.71M$ -114.25M$ -52.41M$ -36.11M$ -22.16M
Investing Cash Flow
$ 40.02M$ -160.90M$ -8.79M$ -14.10M$ -1.29M
Financing Cash Flow
$ 141.17M$ 337.11M$ 58.12M$ 11.88M$ 72.52M
End Cash Position
$ 124.64M$ 97.17M$ 35.21M$ 38.29M$ 76.62M
Free Cash Flow
$ -153.72M$ -116.45M$ -53.03M$ -36.88M$ -23.44M
Currency in USD

Kyverna Therapeutics, Inc. Cash Flow